AstraZeneca PLC is 1.8x more valuable than ABBOTT LABORATORIES by market capitalization ($286.27 B vs $155.32 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABT | AZN |
|---|---|---|
| Market cap | $155.32 B | $286.27 B |
| US-listed rank | #94 | #45 |
| Revenue (latest FY) | $44.33B | - |
| Net income (latest FY) | $6.52B | - |
| Net margin | 14.7% | - |
| P/E (trailing FY) | 23.8 | - |
| SEC filings | 1,001 | 1,004 |
AstraZeneca PLC is 1.8x more valuable than ABBOTT LABORATORIES by market capitalization ($286.27 B vs $155.32 B).
Full pages: ABBOTT LABORATORIES and AstraZeneca PLC, or browse the full rankings.